News & Events

• November 9, 2011
  

  The Patient-Reported Outcome Consortium: Filling Measurement Gaps for PRO End Points to Support Labeling Claims

• August 2, 2011
  

  Development and Evaluation of a Genomic Signature for the Prediction and Mechanistic Assessment of Nongenotoxic Hepatocarcinogens in the Rat

  Fielden M.R., Adai A, Dunn R.T. 2nd, Olaharski A, Searfoss G, Sina J, Aubrecht J, Boitier E, Nioi P, Auerbach S, Jacobson-Kram D, Raghavan N, Yang Y, Kincaid A, Sherlock J, Chen S.J., Car B; Predictive Safety Testing Consortium, Carcinogenicity Working Group. (2011) Development and Evaluation of a Genomic Signature for the Prediction and Mechanistic Assessment of Nongenotoxic Hepatocarcinogens in the Rat. Toxicological Sciences: an official journal of the Society of Toxicology. Nov;124(1):54-74.

• July 11, 2011
  

  The Development of a SPSS Data Dictionary and Syntax for Optimizing the Utilization of the Coalition Against Major Diseases (CAMD) AD Clinical Trial Datasets

• September 1, 2010
  

  Translational Medicine and the Value of Biomarker Qualification

• September 1, 2010
  

  Pharmacometrics As A Discipline Is Entering The “Industrialization” Phase: Standards, Automation, Knowledge Sharing, And Training Are Critical For Future Success